Protein kinase C isoforms differentially phosphorylate human choline acetyltransferase regulating its catalytic activity

被引:23
作者
Dobransky, T
Doherty-Kirby, A
Kim, AR
Brewer, D
Lajoie, G
Rylett, RJ [1 ]
机构
[1] Univ Western Ontario, Dept Physiol & Pharmacol, London, ON N6A 5C1, Canada
[2] Univ Western Ontario, Dept Biochem, London, ON N6A 5C1, Canada
[3] Cell Biol Res Grp, London, ON N6A 5C1, Canada
[4] Robarts Res Inst, London, ON N6A 5C1, Canada
关键词
D O I
10.1074/jbc.M407085200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Choline acetyltransferase ( ChAT) synthesizes acetylcholine in cholinergic neurons; regulation of its activity or response to physiological stimuli is poorly understood. We show that ChAT is differentially phosphorylated by protein kinase C (PKC) isoforms on four serines (Ser-440, Ser-346, Ser-347, and Ser-476) and one threonine (Thr-255). This phosphorylation is hierarchical, with phosphorylation at Ser-476 required for phosphorylation at other serines. Phosphorylation at some, but not all, sites regulates basal catalysis and activation. Ser-476 with Ser-440 and Ser-346/347 maintains basal ChAT activity. Ser-440 is targeted by Arg-442 for phosphorylation by PKC. Arg-442 is mutated spontaneously (R442H) in congenital myasthenic syndrome, rendering ChAT inactive and causing neuromuscular failure. This mutation eliminates phosphorylation of Ser-440, and Arg-442, not phosphorylation of Ser-440, appears primarily responsible for ChAT activity, with Ser-440 phosphorylation modulating catalysis. Finally, basal ChAT phosphorylation in neurons is mediated predominantly by PKC at Ser-476, with PKC activation increasing phosphorylation at Ser-440 and enhancing ChAT activity.
引用
收藏
页码:52059 / 52068
页数:10
相关论文
共 46 条
[1]   Protein kinase c isoforms as therapeutic targets in nervous system disease states [J].
Battaini, F .
PHARMACOLOGICAL RESEARCH, 2001, 44 (05) :353-361
[2]  
BELL RM, 1991, J BIOL CHEM, V266, P4661
[3]   SUBSTRATE PHOSPHORYLATION CAN INHIBIT PROTEOLYSIS BY TRYPSIN-LIKE ENZYMES [J].
BENOREPARSONS, M ;
SEIDAH, NG ;
WENNOGLE, LP .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1989, 272 (02) :274-280
[4]   The cholinergic neuronal phenotype in Alzheimer's disease [J].
Blusztajn, JK ;
Berse, B .
METABOLIC BRAIN DISEASE, 2000, 15 (01) :45-64
[5]   Choline acetyltransferase mRNA expression in the striatal neurons of patients with Alzheimer's disease [J].
Boissiere, F ;
Faucheux, B ;
Agid, Y ;
Hirsch, EC .
NEUROSCIENCE LETTERS, 1997, 225 (03) :169-172
[6]   THE PHOSPHORYLATION OF CHOLINE-ACETYLTRANSFERASE [J].
BRUCE, G ;
HERSH, LB .
NEUROCHEMICAL RESEARCH, 1989, 14 (07) :613-620
[7]   Choline acetyltransferase structure reveals distribution of mutations that cause motor disorders [J].
Cai, YY ;
Cronin, CN ;
Engel, AG ;
Ohno, K ;
Hersh, LB ;
Rodgers, DW .
EMBO JOURNAL, 2004, 23 (10) :2047-2058
[8]   A VIRAL CLEAVAGE SITE CASSETTE - IDENTIFICATION OF AMINO-ACID SEQUENCES REQUIRED FOR TOBACCO ETCH VIRUS POLYPROTEIN PROCESSING [J].
CARRINGTON, JC ;
DOUGHERTY, WG .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (10) :3391-3395
[9]   Protein kinase c isoenzyme patterns characteristically modulated in early prostate cancer [J].
Cornford, P ;
Evans, J ;
Dodson, A ;
Parsons, K ;
Woolfenden, A ;
Neoptolemos, J ;
Foster, CS .
AMERICAN JOURNAL OF PATHOLOGY, 1999, 154 (01) :137-144
[10]   Redesign of choline acetyltransferase specificity by protein engineering [J].
Cronin, CN .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (38) :24465-24469